ALLMedicine™ Atopic Dermatitis Center
Research & Reviews 6,999 results
Pediatric Allergy and Immunology : Official Publication O... Beheshti R, Halstead S et. al.
Jun 28th, 2022 - The pathophysiology of atopic dermatitis (AD) is multifactorial, impacted by individual medical, demographic, environmental, and immunologic factors. This study used multi-omic analyses to assess how host and microbial factors could contribute to ...
Journal of the American Academy of Dermatology; Sheth AP, Blumstein AJ et. al.
Jun 27th, 2022 - Three-Question Skindex-Mini Measures Quality of Life in Children with Atopic Dermatitis.|2022|Sheth AP,Blumstein AJ,Rangel S,Jackson KL,Lai JS,|
Annals of the Rheumatic Diseases; Shirai Y, Nakanishi Y et. al.
Jun 27th, 2022 - Autoimmune and allergic diseases are outcomes of the dysregulation of the immune system. Our study aimed to elucidate differences or shared components in genetic backgrounds between autoimmune and allergic diseases. We estimated genetic correlatio...
Dermatologic Therapy; Bracho-Borro M, Franco-Ruiz PA et. al.
Jun 26th, 2022 - Most patients with atopic dermatitis (AD) have a good response to topical treatment. However, some need systemic therapy in order to satisfactorily control the disease. Azathioprine is an accessible drug for patients in many countries, including u...
The Journal of Investigative Dermatology; Morimoto A, Fukuda K et. al.
Jun 26th, 2022 - TMEM79 is a predisposing gene for atopic dermatitis (AD). Tmem79-deficient mice develop spontaneous dermatitis in a biphasic pattern. The 1st-phase dermatitis is unique, as it occurs independent of microbiota status, whereas the 2nd-phase dermatit...
Guidelines 9 results
Dermatology Online Journal; Yim RM, Singh I et. al.
Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...
Allergy Vultaggio A, Agache I et. al.
Jun 6th, 2020 - The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pandemic re-shaped doctor-patient interaction and challenged capacities of healthcare systems. It created many issues around the optimal and safest way to treat complex pat...
Journal of the European Academy of Dermatology and Venere... Vestergaard C, Wollenberg A et. al.
Jun 25th, 2019 - Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, including a large number of adults of reproductive age. Several guidelines for the treatment of AD exist, yet specific recommendations for the trea...
Journal of the European Academy of Dermatology and Venere... Wollenberg A, Barbarot S et. al.
Apr 21st, 2018 - This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a consensus-based guideline, taking available evidence from other guidelines, systematic revi...
The Journal of Allergy and Clinical Immunology; Huang YJ, Marsland BJ et. al.
Mar 5th, 2017 - PRACTALL is a joint initiative of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology to provide shared evidence-based recommendations on cutting-edge topics in the field of allergy and ...
Drugs 482 results see all →
Clinicaltrials.gov 1,025 results
Jun 24th, 2022 - BACKGROUND: The use of antibiotics has revolutionized medicine, yet the impact of antimicrobials on the human microbiome is incompletely understood. Antimicrobial treatments, including topical and systemic antibiotics, are highly effective and are...
Jun 24th, 2022 - The primary objective of this research is to perform in vivo assessment of the metabolic signatures associated with immunity, with particular focus on the immune modulators of wound healing and tissue repair. Perhaps the most demonstrative example...
Jun 24th, 2022 - This is a randomized, controlled, parallel design, open-label phase 2 clinical study to compare the efficacy of the two proactive treatment arms versus the reactive arm, for the prevention of atopic dermatitis in children at high risk of food alle...
Jun 24th, 2022 - Allergic inflammation is central to the pathogenesis of allergic diseases, including atopic dermatitis, asthma, allergic rhinitis, and food allergy. These disorders are common, affecting up to 50 million Americans, and their pathophysiology remain...
Jun 24th, 2022 - Allergy skin prick tests and measurement of food-specific immunoglobulin E (IgE) levels are common but not robust means to diagnose food allergy, so patients may be placed on overly restrictive food elimination diets as a result of false positive ...
News 1,478 results
Jun 24th, 2022 - Jonathan Silverberg, MD, PhD, MPH, feels fortunate to have had the opportunity to learn from outstanding mentors throughout his career in treating atopic dermatitis (AD). The one mentor who helped shape his philosophy and approach the most was Jon...
Jun 24th, 2022 - Jonathan Silverberg, MD, PhD, MPH, recalls an impactful patient experience as a junior attending physician with a patient with skin of color who presented with severe atopic dermatitis, despite previously being told that it was psychogenic itch. U...
Jun 23rd, 2022 - Key clinical point: The prevalence of keratosis pilaris (KP) was low in Finnish patients with atopic dermatitis (AD), with no evidence of KP serving as a predictor of AD severity or its early onset. Major finding: KP was less frequent in patients.
Jun 23rd, 2022 - Key clinical point: A substantial proportion of adults with atopic dermatitis showed contact hypersensitivity to preservatives (PCHS), thus highlighting the need for patch testing in case of worsening skin symptoms because of topical medications o.
Jun 23rd, 2022 - Key clinical point: In a real-world setting, patients initiating dupilumab reported longstanding moderate-to-severe atopic dermatitis (AD) with frequent type 2 comorbidities and poor quality of life (QoL). Major finding: Patients reported experien.